Nanoemulsion Market

Industry Outlook

The global nanoemulsion market is projected to reach US$ 14,760.4 million by 2026, up from US$ 6,827.5 million in 2017, growing at a CAGR of 8.9% during the forecast period from 2018 to 2026. Technically, nanoemulsions are thermodynamically stable, isotropic, translucent, or transparent, and dispersions of oil and water are stabilized with film-linking surfactant molecules with a droplet size of 20 to 500 nm. Nanoemulsions are widely used in several applications, such as vaccine delivery, DNA-encoded drugs, antibiotics, cosmetics, and topical preparations. The key advantages of nanoemulsions are the elimination of inconsistencies in absorption, enhancement of the absorption rate, assistance with the solubility of lyophilic drugs, increased bioavailability, and high thermodynamic stability. The key factors restraining the growth of the nanopharmaceuticals market are the demand for improved characterization, potential toxicity issues, the absence of explicit regulatory guidelines, unorganized cost-benefit strategies, and the declining interest of a few healthcare professionals.

Market Synopsis

The intravenous route will grow significantly throughout the forecast period due to ongoing expansion in different therapeutic areas.

Emulsions deliver a central oil core stably dispersed in water, which can act as a reservoir for hydrophobic drugs. Emulsions are preferred for topical administration, but the small size of nanoemulsions makes them attractive for parenteral delivery. In addition to solubilizing hydrophobic drugs, emulsions can reduce pain or irritation upon injection, improve pharmacokinetics, allow for new forms of administration, and provide for sustained or targeted release. Nanoemulsion is ideal for parenteral delivery compared to macroemulsion due to higher bioavailability and a longer residence time in the body. Mucosal vaccines manufactured with nanoemulsion assist needle-free immunization by transporting recombinant protein and deactivated organisms to a mucosal surface, where nanoemulsion leads the protein surface to be adjuvanted and facilitates uptake by antigen-presenting cells. Thus, intravenous routes are expected to grow significantly during the forecast period from 2018 to 2026.

Increasing demand for formulations with high bioavailability and therapeutic efficiency is assisting the growth of the nanoemulsion market in Asia-Pacific.

Asia Pacific was the fastest-growing nanoemulsion market throughout the forecast period from 2018 to 2026 due to key driving factors such as developing pharmaceutical research and development infrastructure, rising awareness related to early disease diagnosis and treatment, and incessant research in the field of nanoemulsion technology. In 2017, North America dominated the nanoemulsion market and was expected to maintain its dominance throughout the forecast period. The key factors responsible for North America’s growth include technologically advanced research and development facilities, increasing demand for efficient drug formulations, and key market players based in this region.

Periods of History and Forecast

The nanoemulsion market was analyzed considering current market trends for the base year of 2017, and based on future trends, CAGRs were calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

This report on the nanoemulsion market offers in-depth information related to market dynamics and global trends. The report provides a comprehensive summary of the global nanoemulsion market by segmenting the market based on the route of administration, application, and geography. The objective of publishing this in-depth research report is to assist industry stakeholders in carrying out decisions and strategy implementation in the nanoemulsion market.

This report further describes the major qualitative assessment factors, including key market trends, market drivers, and market restraints, to assist in a better understanding of the global nanoemulsion market. Furthermore, the key players were analyzed graphically based on their product offerings, market strategies, and business strengths. The report also provides an attractive investment proposition based on the extensive geographical research carried out based on PESTEL analysis. Key players profiled in the report include AbbVie Inc., Allergan plc, AstraZeneca plc, Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., Covaris, Inc., NanoBio Corporation, Novartis AG, GlaxoSmithKline plc, and Sanofi S.A., among others.

Key questions are answered in this report.

• What are nanoemulsions and their evolving applications?
• How do routes of administration play a key role in nanoemulsion technology?
• What are the recent market trends and growth opportunities for the companies operating in the nanoemulsion industry?
• Which are the most attractive markets geographically for nanoemulsion technology?
• Which is the fastest-growing application of nanoemulsion?
• What is the competitive landscape of the nanoemulsion market?

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Nanoemulsion Market Portraiture
2.2. Global Nanoemulsion Market, By Route of Administration, 2017 (US$ Mn)
2.3. Global Nanoemulsion Market, By Application Type, 2017 (US$ Mn)
2.4. Global Nanoemulsion Market, by Geography, 2017 Vs 2026 (Value %)

Chapter 3. Global Nanoemulsion Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Nanoemulsion Technologies: Future Trends
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Nanoemulsion Market, by Route of Administration, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Topical Route
4.3. Ocular Route
4.4. Intravenous Route
4.5. Intranasal Route
4.6. Oral Route

Chapter 5. Global Nanoemulsion Market, By Application, 2016 – 2026 (US$)
5.1. Overview
5.2. Antimicrobial
5.3. Cosmetic
5.4. Oncology
5.5. Prophylactic in Bioterrorism
5.6. Mucosal Vaccines
5.7. Cell Culture Technology
5.8. Others (non-toxic disinfectants & gene delivery vector among others)

Chapter 6. Global Nanoemulsion Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America Nanoemulsion Market Analysis, 2016 – 2026
6.2.1. North America Nanoemulsion Market, By Route of Administration, 2016 – 2026 (US$ Mn)
6.2.2. North America Nanoemulsion Market, By Application Type, 2016 – 2026 (US$ Mn)
6.2.3. North America Nanoemulsion Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Nanoemulsion Market Analysis, 2016 – 2026
6.3.1. Europe Nanoemulsion Market, By Route of Administration, 2016 – 2026 (US$ Mn)
6.3.2. Europe Nanoemulsion Market, By Application Type, 2016 – 2026 (US$ Mn)
6.3.3. Europe Nanoemulsion Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Nanoemulsion Market Analysis, 2016 – 2026
6.4.1. Asia Pacific Nanoemulsion Market, By Route of Administration, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific Nanoemulsion Market, By Application Type, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific Nanoemulsion Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America Nanoemulsion Market Analysis, 2016 – 2026
6.5.1. Latin America Nanoemulsion Market, By Route of Administration, 2016 – 2026 (US$ Mn)
6.5.2. Latin America Nanoemulsion Market, By Application Type, 2016 – 2026 (US$ Mn)
6.5.3. Latin America Nanoemulsion Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Nanoemulsion Market Analysis, 2016 – 2026
6.6.1. MEA Nanoemulsion Market, by Route of Administration, 2016 – 2026 (US$ Mn)
6.6.2. MEA Nanoemulsion Market, By Application Type, 2016 – 2026 (US$ Mn)
6.6.3. MEA Nanoemulsion Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. AbbVie Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Allergan plc
7.3. AstraZeneca plc
7.4. Fresenius Kabi AG
7.5. Kaken Pharmaceutical Co., Ltd.
7.6. Covaris, Inc.
7.7. NanoBio Corporation
7.8. Novartis AG
7.9. GlaxoSmithKline plc
7.10. Sanofi S.A.

List of Figures

FIG. 1 Nanoemulsion: Market Segmentation
FIG. 2 Global Nanoemulsion Market Share, By Route of Administration, 2017 (US$ Mn)
FIG. 3 Global Nanoemulsion Market Share, By Application Type, 2017 (US$ Mn)
FIG. 4 Global Nanoemulsion Market, by Geography, 2017 Vs 2026 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2017
FIG. 6 Market Competition Landscape, by Key Players, 2017
FIG. 7 Global Nanoemulsion Market for Topical Route, 2016 – 2026 (US$ Mn)
FIG. 8 Global Nanoemulsion Market for Ocular Route, 2016 – 2026 (US$ Mn)
FIG. 9 Global Nanoemulsion Market for Intravenous Route, 2016 – 2026 (US$ Mn)
FIG. 10 Global Nanoemulsion Market for Intranasal Route, 2016 – 2026 (US$ Mn)
FIG. 11 Global Nanoemulsion Market for Oral Route, 2016 – 2026 (US$ Mn)
FIG. 12 Global Nanoemulsion Market for Antimicrobial Application, 2016 – 2026 (US$ Mn)
FIG. 13 Global Nanoemulsion Market for Cosmetic, 2016 – 2026 (US$ Mn)
FIG. 14 Global Nanoemulsion Market for Oncology, 2016 – 2026 (US$ Mn)
FIG. 15 Global Nanoemulsion Market for Prophylactic in Bioterrorism Application, 2016 – 2026 (US$ Mn)
FIG. 16 Global Nanoemulsion Market for Mucosal Vaccines Application, 2016 – 2026 (US$ Mn)
FIG. 17 Global Nanoemulsion Market for Cell Culture Technology Application, 2016 – 2026 (US$ Mn)
FIG. 18 Global Nanoemulsion Market for Other Applications, 2016 – 2026 (US$ Mn)
FIG. 19 U.S. Nanoemulsion Market, 2016 – 2026 (US$ Mn)
FIG. 20 Canada Nanoemulsion Market, 2016 – 2026 (US$ Mn)
FIG. 21 U.K. Nanoemulsion Market, 2016 – 2026 (US$ Mn)
FIG. 22 Germany Nanoemulsion Market, 2016 – 2026 (US$ Mn)
FIG. 23 Rest Of Europe Nanoemulsion Market, 2016 – 2026 (US$ Mn)
FIG. 24 Japan Nanoemulsion Market, 2016 – 2026 (US$ Mn)
FIG. 25 China Nanoemulsion Market, 2016 – 2026 (US$ Mn)
FIG. 26 Rest Of Asia Pacific Nanoemulsion Market, 2016 – 2026 (US$ Mn)
FIG. 27 Brazil Nanoemulsion Market, 2016 – 2026 (US$ Mn)
FIG. 28 Mexico Nanoemulsion Market, 2016 – 2026 (US$ Mn)
FIG. 29 Rest Of Latin America Nanoemulsion Market, 2016 – 2026 (US$ Mn)
FIG. 30 GCC Nanoemulsion Market, 2016 – 2026 (US$ Mn)
FIG. 31 Rest Of Middle East And Africa Nanoemulsion Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Nanoemulsion Market, By Route of Administration, 2016 – 2026 (US$ Mn)
TABLE 2 Global Nanoemulsion Market, By Application Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Nanoemulsion Market, By Geography, 2016 – 2026 (US$ Mn)
TABLE 4 North America Nanoemulsion Market, By Route of Administration, 2016 – 2026 (US$ Mn)
TABLE 5 North America Nanoemulsion Market, By Application Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America Nanoemulsion Market, By Country/Region, 2016 – 2026 (US$ Mn)
TABLE 7 Europe Nanoemulsion Market, By Route of Administration, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Nanoemulsion Market, By Application Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Nanoemulsion Market, By Country/Region, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific Nanoemulsion Market, By Route of Administration, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Nanoemulsion Market, By Application Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Nanoemulsion Market, By Country/Region, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America Nanoemulsion Market, By Route of Administration, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Nanoemulsion Market, By Application Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Nanoemulsion Market, By Country/Region, 2016 – 2026 (US$ Mn)
TABLE 16 Middle East And Africa Nanoemulsion Market, By Route of Administration, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East And Africa Nanoemulsion Market, By Application Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East And Africa Nanoemulsion Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 19 AbbVie Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Allergan plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 AstraZeneca plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Fresenius Kabi AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Kaken Pharmaceutical Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Covaris, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 NanoBio Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 GlaxoSmithKline plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Sanofi S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)